1.73
-0.03(-1.70%)
Currency In USD
| Previous Close | 1.76 |
| Open | 1.75 |
| Day High | 1.78 |
| Day Low | 1.72 |
| 52-Week High | 6.85 |
| 52-Week Low | 1.59 |
| Volume | 175,223 |
| Average Volume | 147,288 |
| Market Cap | 35.63M |
| PE | -5.77 |
| EPS | -0.3 |
| Moving Average 50 Days | 2.35 |
| Moving Average 200 Days | 3.23 |
| Change | -0.03 |
If you invested $1000 in PetMed Express, Inc. (PETS) 10 years ago, it would be worth $138.16 as of December 05, 2025 at a share price of $1.73. Whereas If you bought $1000 worth of PetMed Express, Inc. (PETS) shares 5 years ago, it would be worth $67.94 as of December 05, 2025 at a share price of $1.73.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PetMeds Extends Existing Shareholder Rights Plan
GlobeNewswire Inc.
Nov 26, 2025 9:05 PM GMT
DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors (the “Board”) has unanimously approved an amendme
PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq
GlobeNewswire Inc.
Nov 13, 2025 1:00 PM GMT
DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, N
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
GlobeNewswire Inc.
Oct 20, 2025 12:30 PM GMT
Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds an